Si-Bone (SIBN) - Stock Price & Dividends

Si-Bone Inc, listed on the NASDAQ as SIBN, is a medical technology company specializing in developing innovative implantable devices to address musculoskeletal disorders of the sacropelvic anatomy globally.

The company's flagship product is the proprietary minimally invasive surgical implant system, which caters to a range of conditions such as sacroiliac joint dysfunction, adult deformity, degeneration, and pelvic trauma.

Si-Bone Inc's innovative products include the iFuse-3D titanium implant, combining a unique triangular cross-section with a 3D-printed porous surface and fenestrated design. Additionally, the iFuse-TORQ offers 3D-printed threaded implants for pelvic trauma treatment, while the iFuse Bedrock Granite implant serves as a foundational element for sacroiliac fusion and sacropelvic fixation during segmental spinal fusion.

Operational since 2008, Si-Bone Inc is headquartered in Santa Clara, California, and markets its cutting-edge products through a direct sales force, agents, and distributors. To learn more, visit their website at https://si-bone.com.